| Enrolling By Invitation | Adaptive Neoadjuvant Therapy for Esophageal Cancer NCT06990178 | Cancer Hospital Chinese Academy of Medical Science, Shenzhen Center | N/A |
| Not Yet Recruiting | Camrelizumab, Chemotherapy and Ivarmacitinib in Patients With Resectable Esophageal Squamous Cell Carcinoma NCT07505186 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 2 |
| Not Yet Recruiting | Pragmatic Study to Optimize Neoadjuvant Treatment and Surgical De-escalation in HR+/HER2- Early Breast Cancer NCT07428018 | Mario Negri Institute for Pharmacological Research | Phase 2 |
| Not Yet Recruiting | Neoadjuvant Therapy for Early Triple-Negative Breast Cancer: A Response-Guided Approach Using Iparomlimab and NCT07372079 | Tianjin Medical University Cancer Institute and Hospital | Phase 2 |
| Recruiting | Neoadjuvant Chemoradiotherapy Plus Tislelizumab With or Without Probio-M9 in pMMR/MSS Locally Advanced Rectal NCT07458529 | Seventh Medical Center of PLA General Hospital | Phase 2 |
| Recruiting | Fulzerasib Sequential Sintilimab Plus Platinum-Doublet Neoadjuvant Therapy for Resectable KRAS G12C-Mutant NSC NCT07492342 | Jianxing He | Phase 2 |
| Not Yet Recruiting | Phase II Basket Trial: Zanidatamab Plus Tislelizumab in HER2-Positive GI Tumors (UNION-HER2-BASKET) NCT07243938 | Tao Zhang | Phase 2 |
| Recruiting | Sintilimab Plus Bevacizumab Biosimilar as Neoadjuvant Therapy for Resectable Hepatocellular Carcinoma NCT07324824 | Sun Yat-sen University | Phase 2 |
| Recruiting | Perioperative Outcomes After Neoadjuvant Therapy in Colorectal Cancer NCT07422974 | Osijek University Hospital | — |
| Not Yet Recruiting | Neoadjuvant Chemotherapy for Elderly with Pancreatic Head Cancer NCT06868693 | Azienda Unita Sanitaria Locale di Piacenza | — |
| Recruiting | Circulating microRNAs and Response to Neoadjuvant Chemotherapy in Breast Cancer NCT07289282 | Atlas University | — |
| Recruiting | A Phase Ib Trial Evaluating the Safety and Activity of Neoadjuvant Combination of Tislelizumab Plus FLOT for R NCT07059299 | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | Phase 1 |
| Recruiting | Prediction of Outcome to Neoadjuvant Therapy in Non-small Cell Lung Cancer（NSCLC） NCT07388771 | Qian Chu | — |
| Not Yet Recruiting | Development and Application of AI-Based Therapeutic Strategies for Esophageal Cancer Integrating Multimodal Im NCT07203690 | Henan Cancer Hospital | — |
| Not Yet Recruiting | Neoadjuvant Ivonescimab（AK112） Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell NCT07244978 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 2 |
| Not Yet Recruiting | Adebrelimab Combined With Chemotherapy for Neoadjuvant Therapy in Resectable Pancreatic Cancer NCT06177522 | Jinling Hospital, China | Phase 2 |
| Recruiting | Iparomlimab and Tuvonralimab (QL1706) Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC NCT07389629 | Sun Yat-sen University | Phase 2 |
| Not Yet Recruiting | A Prospective, Single-center, Phase II Study of Sacituzumab Tirumotecan in Combination With Pembrolizumab for NCT07054242 | Yantai Yuhuangding Hospital | Phase 2 |
| Not Yet Recruiting | Neoadjuvant CAPOX Plus Tislelizumab vs CAPOX in MSS High-Risk Locally Advanced Colon Cancer NCT07132008 | First Affiliated Hospital of Guangxi Medical University | Phase 3 |
| Not Yet Recruiting | Vebreltinib for Neoadjuvant in METex 14 Skipping Mutant Stage IIA-IIIB (N2) Non-small Cell Lung Cancer (NSCLC) NCT07156604 | Fudan University | Phase 2 |
| Not Yet Recruiting | Family-Supervised Prehabilitation to Reduce Postoperative Complications After Neoadjuvant Chemotherapy in Gast NCT07183358 | The Affiliated Hospital of Qingdao University | N/A |
| Not Yet Recruiting | Simple Surgical Glove Compression to Prevent Chemotherapy-Induced Peripheral Neuropathy NCT07169864 | Jinsong Lu | N/A |
| Recruiting | Sleeve Lobectomy Following Neoadjuvant Therapy in NSCLC NCT07135856 | Shanghai Chest Hospital | — |
| Recruiting | Long-course Chemoradiotherapy or Short-course Radiotherapy Combined With CAPOX, PD-1antibody, and COX-2 Inhibi NCT07150949 | Fudan University | Phase 2 |
| Not Yet Recruiting | Envafolimab Combined With Neoadjuvant Chemotherapy Treat Stage IIb Resectable Osteosarcoma Patients NCT07142863 | Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine | Phase 2 |
| Active Not Recruiting | Neoadjuvant Chemotherapy Before Surgery vs Surgery Alone for UTUC: A Randomized Trial NCT07492225 | Changhai Hospital | Phase 2 |
| Not Yet Recruiting | A Phase II Randomized Trial of Neoadjuvant Ivonescimab or Penpulimab Plus Chemotherapy in Resectable NSCLC NCT07086326 | Yang Fan, MD | Phase 2 |
| Recruiting | Neoadjuvant Radiotherapy Plus Tegafur, Oxaliplatin and Iparomlimab and Tuvonralimab in Resectable Gastric and NCT07165847 | Daping Hospital and the Research Institute of Surgery of the Third Military Medical University | Phase 2 |
| Recruiting | Pucotenlimab Combination With Vorolanib as Neoadjuvant Therapy for ccRCC NCT07386158 | Sun Yat-sen University | Phase 2 |
| Recruiting | Neoadjuvant Tislelizumab + Nab-Paclitaxel Followed by Distal Ureterectomy for Ureteral Cancer NCT07125547 | Tianjin Medical University Second Hospital | Phase 2 |
| Recruiting | Neoadjuvant Tislelizumab in Combination With Nab-Paclitaxel for UTUC NCT07126119 | Tianjin Medical University Second Hospital | Phase 2 |
| Active Not Recruiting | Mechanism of Enhanced Efficacy of Ivonescimab in Neoadjuvant Therapy for Non-Small Cell Lung Cancer NCT07359040 | Peking University People's Hospital | — |
| Not Yet Recruiting | Benmelstobart-Anlotinib-Chemo for Neoadjuvant Oral Cancer NCT06848439 | Jiangsu Cancer Institute & Hospital | Phase 2 |
| Recruiting | A Clinical Trial of Neoadjuvant Targeted Therapy, Immunotherapy, and Lysogenic HSV-Based Virotherapy in Resect NCT07010120 | West China Hospital | Phase 1 / Phase 2 |
| Recruiting | No Axillary Surgical Treatment in Clinically Lymph Node Negative Patients on Ultrasonography After Neoadjuvant NCT06704945 | Seoul National University Hospital | Phase 3 |
| Recruiting | FAP-targeted PET/NIR in Lung Malignant Tumors NCT07498933 | Peking University People's Hospital | — |
| Not Yet Recruiting | Iparomlimab and Tuvonralimab Combined With Platinum-Based Chemotherapy for Neoadjuvant Treatment of Cervical C NCT06986057 | Shandong Tumor Hospital | Phase 2 |
| Recruiting | Neoadjuvant Cadonilimab Combined With Perioperative Oxaliplatin Plus S1 for Diffuse or Mixed Type of Locally A NCT06949033 | Zuoyi Jiao | Phase 3 |
| Recruiting | To Conduct Multi-omics Integrated Studies in Peripheral Blood, Such as Fragment Omics, Metabolomics and Epigen NCT07291921 | Peking University People's Hospital | — |
| Recruiting | Using 4D Urinary Proteomics to Predict and Evaluate Treatment Response in Colorectal Cancer NCT06904677 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | — |
| Not Yet Recruiting | Comparison of Neoadjuvant Cadonilimab Versus Chemotherapy Combined With PD-1 in the Treatment of Resectable No NCT06946836 | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 |
| Recruiting | A Clinical Study on the Efficacy and Safety of Paclitaxel Polymeric Micelles and Cisplatin Combined With Cadon NCT06356688 | Sun Jing | Phase 2 |
| Recruiting | Neoadjuvant Apatinib Combined With Sintilimab and Perioperative SOX Versus Neoadjuvant Sintilimab Combined Wit NCT06925243 | Zuoyi Jiao | Phase 3 |
| Recruiting | Neoadjuvant SNF Precision Therapy Phase III NCT06913777 | Fudan University | Phase 3 |
| Not Yet Recruiting | Paclitaxel Polymeric Micelles and Carboplatin in Combination With Iparomilimab and Tuvonralimab Neoadjuvant Th NCT06910072 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 / Phase 3 |
| Not Yet Recruiting | Evaluation of Neoadjuvant Therapy Efficacy and Postoperative Pathological Indicators in Esophageal Cancer Usin NCT06833775 | Henan Cancer Hospital | — |
| Recruiting | Reduce Sedentary Behavior During Cancer Treatment - the RedSedCan Study NCT06719206 | Mälardalen University | N/A |
| Not Yet Recruiting | Study of Sinibolimab Combined with Lenvatinib As Neoadjuvant Therapy for Locally Advanced Unresectable Differe NCT06848920 | Zhejiang University | Phase 2 |
| Recruiting | Question Prompt List in Breast Cancer Patients Planned for Neoadjuvant Chemotherapy NCT06777420 | Region Örebro County | N/A |
| Not Yet Recruiting | Efficacy and Safety of Ensartinib in Neoadjuvant Therapy for Stage IIA - IIIB (Operable or Potentially Operabl NCT06785584 | Fujian Medical University Union Hospital | Phase 4 |
| Not Yet Recruiting | Phase I/II Study of Neoadjuvant Cemiplimab and Dupilumab in Early-Stage Non-Small Cell Lung Cancer NCT06743581 | Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
| Not Yet Recruiting | Surgery After Verifying Existing Disease in Locally Advanced Operable Lung Cancer: A Pilot Study NCT06743555 | Centre hospitalier de l'Université de Montréal (CHUM) | Phase 1 |
| Completed | The Effect of Neoadjuvant Chemotherapy on Physical Functions NCT06986005 | ATİYE KAŞ ÖZDEMİR | — |
| Recruiting | Total Neoadjuvant Therapy and Organ Preservation Versus Surgery for Rectal Cancer. NCT06758830 | National Cancer Center Affiliate of Vilnius University Hospital Santaros Klinikos | Phase 2 / Phase 3 |
| Recruiting | Exploring the Treatment Duration of PD-1 Neoadjuvant Therapy in Stage II-III dMMR Rectal Cancer NCT06613165 | Xijing Hospital | — |
| Not Yet Recruiting | A Multicenter Real-world Clinical Study on the Efficacy and Safety of Ensartinib As Neoadjuvant Treatment for NCT06736561 | Harbin Medical University | — |
| Active Not Recruiting | Predictive Value of Tumor Vascular Normalization Scoring in HER-2 Positive Breast Cancer NCT06868758 | Chongqing General Hospital | — |
| Not Yet Recruiting | A Prospective Study of Expression Profiling-based Assessment of the Efficacy of Neoadjuvant Therapy for Rectal NCT06746298 | Shanghai Minimally Invasive Surgery Center | — |
| Not Yet Recruiting | Application of MRI Radiomics Features in Neoadjuvant Therapy of Head and Neck Squamous Cell Carcinoma NCT06755567 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Recruiting | A Clinical Study on Neoadjuvant Treatment of Resectable Head and Neck Squamous Carcinoma With Immune-targeted NCT06741982 | West China Hospital | Phase 1 |
| Active Not Recruiting | Application of Targeted Axillary Lymph Node Resection in Axillary Surgery After Neoadjuvant Chemotherapy for B NCT07032220 | Fujian Medical University Union Hospital | N/A |
| Recruiting | Neoadjuvant Chemotherapy Plus Pyrotinib and Trastuzumab for HER2-positive Breast Cancer (NEOTORCH-BREAST05) NCT06832904 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Not Yet Recruiting | Neoadjuvant Therapy of Targeted Immunotherapy Combined With Chemotherapy for Locally Advanced HNSCC NCT06699498 | The First Affiliated Hospital with Nanjing Medical University | Phase 2 |
| Recruiting | Neoadjuvant Immunotherapy Plus Chemotherapy Followed by Concurrent Chemoradiotherapy and Consolidative Immunot NCT06734702 | Sun Yat-sen University | Phase 3 |
| Recruiting | Effect of Vitamin D Supplementation on the Efficacy and Adverse Effects of Neoadjuvant Therapy in Patients wit NCT06642428 | Jiuda Zhao | N/A |
| Recruiting | Short-course Radiotherapy Followed by AK112 and CAPOX as Neoadjuvant Therapy for Locally Advanced Rectal Cance NCT06802666 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 |
| Not Yet Recruiting | Living Donor Liver Transplantation for Intrahepatic Cholangiocarcinoma NCT06539377 | Jena University Hospital | N/A |
| Not Yet Recruiting | QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk TNBC Breast Cancer NCT06404736 | Fudan University | Phase 2 |
| Not Yet Recruiting | QL1706 Plus Chemotherapy as Neoadjuvant Therapy in Early High-Risk ER+/HER2- Breast Cancer NCT06404463 | Fudan University | Phase 2 |
| Recruiting | CAPOX and PD-1 Antibody Combined With or Without Radiotherapy for MSS Locally Advanced Rectal Cancer NCT06281405 | Fudan University | Phase 2 |
| Recruiting | A Study of Neoadjuvant Therapy for the Treatment of Patients With Locally Advanced Esophageal Squamous Cell Ca NCT06354530 | Army Medical Center of PLA | Phase 2 / Phase 3 |
| Completed | Effect of Pentoxifylline on Preventing Chemotherapy-induced Toxicities in Patients With Breast Cancer NCT06186700 | Mansoura University | Phase 2 |
| Recruiting | Efficacy and Safety of Neoadjuvant Envafolimab Combined With Albumin-bound Paclitaxel and Carboplatin for Rese NCT07266493 | Shanghai Zhongshan Hospital | Phase 2 |
| Active Not Recruiting | Neoadjuvant Tislelizumab With Chemotherapy for the Treatment of MSS Colon Cancer NCT06124378 | First Affiliated Hospital of Guangxi Medical University | Phase 2 |
| Not Yet Recruiting | PABLIXIMAB as Neoadjuvant Therapy for Head and Neck Squamous-cell Carcinoma NCT06125223 | Xijing Hospital | — |
| Not Yet Recruiting | Neoadjuvant PD-1 Inhibitor Combined With Cetuximab in Operable Locally Advanced HNSCC NCT05993858 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 |
| Not Yet Recruiting | Neoadjuvant Therapy of Anlotinib Combined With Toripalimab and Chemotherapy for Resectable Esophageal Carcinom NCT05996484 | Nanfang Hospital, Southern Medical University | Phase 2 |
| Not Yet Recruiting | Study of Utidelone Based Neoadjuvant Treatment on Early High-risk or Locally Advanced Breast Cancer NCT05983094 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | Phase 2 |
| Completed | Cadonilimab Combination With Lenvatinib as Neoadjuvant Therapy for ccRCC NCT06138496 | Sun Yat-sen University | Phase 2 |
| Unknown | Temporal Diffusion Spectroscopy MRI in Predicting the CPS of PD-L1 Expression and the Efficacy of Neoadjuvant NCT05964595 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Recruiting | Envafolimab Monotherapy or Envafolimab + CAPEOX as Neoadjuvant Therapy for Locally Advanced Colorectal Cancer NCT06014372 | Sun Yat-sen University | Phase 2 |
| Unknown | Cadonilimab as Neoadjuvant Therapy in Resectable Stage II-III MSI-H/dMMR Colorectal Cancer NCT05913570 | LiuYing | Phase 2 |
| Active Not Recruiting | Serplulimab Combined With Chemotherapy in Patients With Resectable Non-small-cell Lung Cancer NCT05882513 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 2 |
| Unknown | Gastric Cancer Organoids in the Screening of Neoadjuvant Drugs NCT06196554 | Dong Bing Zhao | — |
| Recruiting | Evaluating the Efficacy and Safety of Pembrolizumab Plus Standard Chemotherapy in the Neoadjuvant Treatment of NCT06102395 | Beijing Tongren Hospital | Phase 3 |
| Not Yet Recruiting | Cadonilimab in Combination With Chemotherapy for Locally Advaced Esophageal Squamous Cell Carcinoma NCT05833971 | Guangzhou Institute of Respiratory Disease | Phase 2 |
| Completed | Evaluate the Efficacy and Safety of Serplulimab Plus Chemotherapy in Neoadjuvant and Adjuvant Treatment of Res NCT05775796 | Fudan University | Phase 2 |
| Unknown | The Study of Vidicizumab Combined With Tirelizumab in the Treatment of Breast Cancer With Low HER2 Expression NCT05861635 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 4 |
| Unknown | The Clinical Efficacy of Drug Sensitive Neoadjuvant Chemotherapy Based on Organoid Versus Traditional Neoadjuv NCT05352165 | Shanghai Minimally Invasive Surgery Center | N/A |
| Recruiting | Neoadjuvant Camrelizumab Combined With Chemotherapy for Resectable Stage IIIA-IIIB NSCLC NCT06241807 | Shandong Cancer Hospital and Institute | Phase 2 |
| Active Not Recruiting | Serplulimab Combined With Chemotherapy in Patients With Resectable Esophageal Squamous Cell Carcinoma NCT05659251 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 2 |
| Recruiting | Neoadjuvant Triprizumab and Radiotherapy in Operable Patients With Stage IIA-IIIA Non-small Cell Lung Cancer NCT06065813 | Northern Jiangsu People's Hospital | Phase 2 |
| Active Not Recruiting | PD-1 Inhibitor Plus GP as Neoadjuvant Therapy for Locoregionally Advanced Nasopharyngeal Carcinoma NCT05340270 | Guangxi Medical University | Phase 2 |
| Active Not Recruiting | Neoadjuvant/Adjuvant Pembrolizumab Plus Chemotherapy NCT05383716 | Peking Union Medical College Hospital | Phase 2 |
| Active Not Recruiting | Reducing Excision Margins After Neoadjuvant Chemoimmunotherapy for HPV Negative Resectable Locally Advanced HN NCT05459415 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | N/A |
| Completed | Neoadjuvant Treatment Based on Gastric Cancer Molecular Subtyping. NCT06376773 | Fujian Medical University | — |
| Completed | Postoperative Radiotherapy for Oral Squamous Cell Carcinoma After Neoadjuvant Therapy and Surgery NCT05455632 | Shanghai Jiao Tong University School of Medicine | — |
| Unknown | Envafolimab as Neoadjuvant Immuntherapy in Resectable Local Advanced dMMR/MSI-H Colorectal Cancer NCT05371197 | Third Affiliated Hospital, Sun Yat-Sen University | Phase 2 |
| Unknown | A Study of Pamiparib Combined With Abiraterone Acetate in Neoadjuvant Treatment of Prostate Cancer NCT05376722 | Hongqian Guo | Phase 2 |
| Recruiting | Development and Prospective Validation of a Multimodal Fusion Artificial Intelligence Model for Predicting the NCT06909643 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | — |
| Unknown | A Study on the Safety and Effectiveness of Tislelizumab Combined With Axitinib for Neoadjuvant Treatment of cc NCT05172440 | Hongqian Guo | Phase 2 |
| Unknown | Efficacy and Safety of Combinition of Camrelizumab in Second-line Neoadjuvant Chemotherapy and Adjuvant Therap NCT04848454 | Peking University First Hospital | Phase 2 |
| Terminated | Perioperative Chemoimmunotherapy With/Without Preoperative Chemoradiation for Locally Advanced Gastric Cancer NCT05161572 | Fudan University | Phase 2 |
| Unknown | Tislelizumab Combined With Chemotherapy as Neoadjuvant Therapy for Stage IIIA-IIIB (N2) Lung Squamous Cell Car NCT05024266 | First Affiliated Hospital of Zhejiang University | Phase 2 |
| Active Not Recruiting | Phase II Neoadjuvant Pyrotinib Combined with Neoadjuvant Chemotherapy in HER2-low-expressing and HR Positive E NCT05165225 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Phase 2 |
| Unknown | Contrast-enhanced Ultrasonography Combined With Blue Dye as Dual-tracer for Sentinel Lymph Node Biopsy NCT04932460 | First Affiliated Hospital, Sun Yat-Sen University | N/A |
| Unknown | The Validation of Sentinel Lymph Node Biopsy After Neo-adjuvant Chemotherapy in Breast Cancer Patients NCT04986306 | National Cheng-Kung University Hospital | — |
| Completed | Clinical Application of Multi-modal Sentinel Lymph Node Staining Method in Breast Cancer Patients After Neoadj NCT06212440 | National Cancer Center, Korea | N/A |
| Unknown | Fluzoparib and Abiraterone in the preSurgery Treatment of Prostate Cancer: FAST Trial NCT05223582 | Fudan University | Phase 2 |
| Completed | Efficacy and Toxicity of Paclitaxel, Cisplatin Combined With Sindilimab in NACT for Locally Advanced Cervical NCT04799639 | Sun Yat-sen University | Phase 2 |
| Recruiting | Multimodal Prehabilitation During Chemotherapy in Patients With Colorectal Liver Metastases NCT04520737 | Institut Investigacio Sanitaria Pere Virgili | N/A |
| Active Not Recruiting | Chemoradiotherapy Plus Immunotherapy Followed by Surgery for Esophageal Cancer NCT04776590 | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | Phase 2 |
| Completed | Neoadjuvant Therapy for Locally Advanced Colon Cancer NCT04625803 | Zhejiang University | Phase 2 |
| Recruiting | Multi-points and Full-thickness Biopsy in the Diagnosis of cCR After Neoadjuvant Therapy for Rectal Cancer NCT04743102 | Beijing Chao Yang Hospital | N/A |
| Unknown | Combined Atezolizumab and Chemotherapy (Carboplatin Plus Etoposide) in Neoadjuvant Treating Limited-Stage Smal NCT04696939 | Shanghai Pulmonary Hospital, Shanghai, China | Phase 2 |
| Unknown | Toripalimab Combined With Gemcitabine and Cisplatin Treating Resectable Locally Advanced HNSCC NCT04947241 | Fifth Affiliated Hospital, Sun Yat-Sen University | Phase 1 |
| Active Not Recruiting | Carrelizumab, Chemotherapy and Apatinib in the Neoadjuvant Treatment of Resectable Esophageal Squamous Cell Ca NCT04666090 | Second Affiliated Hospital, School of Medicine, Zhejiang University | Phase 2 |
| Unknown | Neoadjuvant Carilizumab and Apatinib for Recurrent High-Grade Glioma NCT04588987 | Sun Yat-sen University | Phase 2 |
| Terminated | Feasibility Study of Intraoperative Detection of Residual Cancer in Breast Cancer Patients NCT04440982 | Lumicell, Inc. | Phase 2 |
| Recruiting | Minimal Invasive Axillary Staging and Treatment After Neoadjuvant Systemic Therapy in Node Positive Breast Can NCT04486495 | Maastricht University Medical Center | — |
| Unknown | A Study to Confirm the Accuracy of Locally Advanced Gastric Cancer Diagnosis NCT04440605 | Peking University | — |
| Unknown | Surveillance of Peripheral Blood of Lymphocyte and Immunocyte in Neoadjuvant Therapy Patients With Esophageal NCT04440332 | Sichuan Cancer Hospital and Research Institute | — |
| Unknown | Toripalimab Combined With Axitinib as Neoadjuvant Therapy for Advanced/Metastatic Non-clear Cell Renal Cell Ca NCT04385654 | West China Hospital | Phase 2 |
| Unknown | Application of Preoperative Axillary Lymph Node Marking With Nano-Carbon in Breast Cancer Patients Before Neoa NCT05512468 | Fujian Medical University Union Hospital | N/A |
| Unknown | Interval Between Neoadjuvant Therapy and Surgery in the Treatment of Locally Advanced Rectal Cancer (CRONOS) NCT04717947 | Hospital Clinic of Barcelona | — |
| Recruiting | Neoadjuvant Intense Endocrine Therapy for High Risk and Locally Advanced Prostate Cancer NCT05406999 | The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School | Phase 2 |
| Unknown | Study on Predictive Biomarkers of Neoadjuvant Chemoradiotherapy for Rectal Cancer NCT04227886 | Fudan University | — |
| Unknown | A Phase II Study of Total Neoadjuvant Therapy for Locally Advanced Gastric Cancer NCT04062058 | Jing Jin, M.D. | Phase 2 |
| Unknown | Study of CT and MR in the Gastric Cancer NCT04028375 | Henan Cancer Hospital | — |
| Recruiting | Neoadjuvant Toripalimab With or Without Celecoxib in dMMR/MSI-H Colorectal Cancer NCT03926338 | Sun Yat-sen University | Phase 2 |
| Recruiting | COGNITION: Genomics-Guided Precision Oncology in Early High-Risk Breast Cancer NCT05906407 | German Cancer Research Center | — |
| Active Not Recruiting | Neoadjuvant Degarelix With or Without Apalutamide (ARN-509) Followed by Radical Prostatectomy NCT03080116 | Universitaire Ziekenhuizen KU Leuven | Phase 2 |
| Completed | Prehabilitation for Women Undergoing Pre-operative Chemotherapy for Breast Cancer NCT03564171 | Sunnybrook Health Sciences Centre | Phase 2 / Phase 3 |
| Completed | Mesenchymal CTC Ratio Dynamics Predicts Response and Survival in Pancreatic Ductal Adenocarcinoma With Neoadju NCT07329920 | Guo ShiWei | — |
| Unknown | Divestment for Artery-involved Pancreatic Cancer NCT03443921 | The First Affiliated Hospital with Nanjing Medical University | N/A |
| Unknown | Apatinib Treatment as the Neoadjuvant Therapy in Advanced Colorectal Cancer NCT03377842 | Sichuan Provincial People's Hospital | Phase 2 |
| Unknown | Apatinib Combined With SOX Neoadjuvant Therapy for Locally Advanced Gastric Cancer NCT03192735 | Chang-Ming Huang, Prof. | Phase 2 |
| Unknown | Application of Circulating Tumor DNA Test in the Diagnosis and Treatment of Patients With Advanced Rectal Canc NCT03615170 | Zhejiang Cancer Hospital | — |
| Completed | Oncolytic Adenovirus, DNX-2401, for Naive Diffuse Intrinsic Pontine Gliomas NCT03178032 | Clinica Universidad de Navarra, Universidad de Navarra | Phase 1 |
| Completed | Validation of the CPS+EG, Neo-Bioscore and Modified Neo-Bioscore Staging Systems After PST of BC in China NCT03437837 | Peking University First Hospital | — |
| Completed | RISAS Procedure in Node Positive Breast Cancer Following NAC NCT02800317 | Erasmus Medical Center | N/A |
| Completed | Robotic Versus Open Surgery Following Neoadjuvant Therapy in Pancreatic Cancer: Evaluation of Safety and Oncol NCT07147374 | Peking Union Medical College Hospital | — |
| Unknown | Endoscopic Assisted Electrochemotherapy in Addition to Neoadjuvant Treatment of Locally Advanced Rectal Cancer NCT03040180 | Zealand University Hospital | Phase 2 |
| Unknown | Aromatase Inhibitors Plus Chemotherapy vs Chemotherapy as Neoadjuvant Treatment in Postmenopausal HR(+) Breast NCT02769104 | Zhejiang Cancer Hospital | Phase 3 |
| Completed | A Randomized Phase II Trial of Neoadjuvant Chemotherapy Compared With Chemoradiotherapy in Gastric Adenocarcin NCT02301481 | Chinese Academy of Medical Sciences | Phase 2 |
| Unknown | Neoadjuvant ECS Versus ECF in Local Advanced Breast Cancer NCT01849380 | Shandong University | Phase 4 |
| Completed | A Study to Correlate Ultrasound Elastography With Histopathology to Monitor the Response of Locally Advanced B NCT01737970 | Oxford University Hospitals NHS Trust | — |
| Completed | The Use of Molecular Breast Imaging in the Evaluation of Tumor Response to Neoadjuvant Therapy in Women With B NCT01023802 | Mayo Clinic | — |
| Completed | Long-term Survival Outcomes According to the Pathologic Response After Neoadjuvant Treatment in PDAC and the F NCT06630481 | Seoul National University Hospital | — |
| Completed | Efficacy of Erlotinib in Neoadjuvant Setting in Patients With Stage IIIA, N2-positive Non-Small Cell Lung Canc NCT01130753 | Samsung Medical Center | Phase 2 |
| Completed | Systematic Lymphadenectomy During Interval Debulking Surgery in Advanced Epithelial Ovarian Cancer NCT06385912 | Tongji Hospital | — |
| Unknown | Preoperative Chemoradiotherapy With Capecitabine Plus Irinotecan in Rectal Cancer NCT00506623 | National Cancer Center, Korea | Phase 2 |